IBB vs. EWL ETF Comparison

Comparison of iShares Nasdaq Biotechnology Index Fund (IBB) to iShares MSCI Switzerland Capped Index Fund (EWL)
IBB

iShares Nasdaq Biotechnology Index Fund

IBB Description

The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$144.77

Average Daily Volume

1,131,268

Number of Holdings *

10

* may have additional holdings in another (foreign) market
EWL

iShares MSCI Switzerland Capped Index Fund

EWL Description The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Switzerland 25/50 Index. The fund will at all times invest at least 80% of its assets in the securities of its underlying index and in depositary receipts ("DRs") representing securities in its underlying index. The MSCI Switzerland 25/50 Index consists of stocks traded primarily on the Zurich Stock Exchange. A capping methodology is applied that limits the weight of any single component to a maximum of 25% of the MSCI Switzerland 25/50 Index. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$51.84

Average Daily Volume

347,183

Number of Holdings *

2

* may have additional holdings in another (foreign) market
Performance
Period IBB EWL
30 Days -2.29% -1.91%
60 Days 0.42% 3.66%
90 Days 7.17% 7.26%
12 Months 20.11% 22.70%
0 Overlapping Holdings
Symbol Grade Weight in IBB Weight in EWL Overlap
Compare ETFs